Bifogade filer
PDF
Beskrivning
| Land | Finland |
|---|---|
| Lista | Spotlight |
| Sektor | Handel & varor |
| Industri | Detaljhandel |
Eevia Health Plc ("Eevia" or "The Company") has completed mandatory cooperation negotiations with its employees regarding reorganization and downsizing. Eevia has 19 employees; seven leave voluntarily, two shift to part-time, and Eevia terminates four employment contracts. The Company will retain nine essential staff, saving KEUR 490 annually in payroll.
Eevia has completed mandatory cooperation negotiations (YT-neuvottelut) as required by the Finnish Act on Cooperation (YT-laki). These negotiations ensure employees can discuss and influence significant workforce changes before implementation.
Eevia has 19 employees. Three are voluntarily resigning, while four will take employment in the receiving businesses for divested assets. Two employment contacts have been reduced to part-time. Four employee contracts have been terminated. Eevia will retain an essential force of nine employees. The Company is expecting annual payroll cost savings of KEUR 490.
These changes take effect in February 2025 and will positively impact Q1-2024 operating costs. The workforce reduction leaves essential capabilities intact, and the Company can deliver the financial revenue target for 2025 of MEUR 3 million with this reduced workforce, with the capability to scale with further revenue growth.
Eevia's new strategy focuses on proanthocyanidin-based gut health solutions, requiring a different workforce. Resources in sales, marketing, and product management will increase, with some new hires offsetting savings. Downsizing aims to restore profitability and align with future needs, enabling growth through science-backed botanical solutions with a lower, flexible cost base.
For further information, please contact:
Stein Ulve, CEO, Eevia Health Plc
Email: stein.ulve@eeviahealth.com or investor@eeviahealth.com
Telephone: +358 400 22 5967
This disclosure contains information that EEVIA HEALTH PLC must make public according to the EU Market Abuse Regulation (EU nr 596/2014). The information was initially submitted for publication through the contact person's agency on February 7, 2025, at 10:15 EST.
INFORMATION ABOUT EEVIA HEALTH PLC
Eevia Health Plc, founded in March 2017, addresses global health challenges with bioactive compounds sustainably extracted from renewable plant materials. It focuses on the gut and related health, including kidney and urinary health.
Eevia Health is a manufacturer of 100% organically certified plant extracts. The materials are primarily wild harvested from the pristine Finnish and Swedish forests near or above the Arctic Circle. The extracts are sold B2B as ingredients to dietary supplements and food brands globally, and these global brands utilize the ingredients in their consumer product formulas.
As a pioneering company, Eevia is developing high-value food ingredients, blended solutions, and biomaterials that significantly benefit human health. Eevia Health operates a modern green-chemistry production facility in Finland with a short value chain and environmentally friendly carbon footprint. Eevia listed its shares at the Spotlight Stock Market in Sweden in June 2021, with the short name (ticker) EEVIA. To learn more, please visit www.eeviahealth.com or follow Eevia Health on LinkedIn@EeviaHealth.